IRCT20190708044158N1已完成3 期
Comparison between the Effect of Fenofibrate and Clofibrate on Term Neonates with Hyperbilirubinemia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 days 至 28 days（—）
- 性别
- All
入选标准
- •Term neonates(37 weeks to 41 weeks and 6 days) that their ages are more than 72 hours.
- •They were admitted for jaundice, total bilirubin serum more than 15 mg/dl.
- •They were otherwise healthy.
- •They did not receive therapy other than phototherapy.
排除标准
- •Premature neonates
- •IUGR infants
- •Neonates with congenital anomaly
- •Neonates with blood group and RH incompatibility
- •Neonates with G6PD deficiency
- •Neonates with history of maternal phenobarbital consumption
- •Neonates with respiratory distress and signs and symptoms of sepsis
研究者
相似试验
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
4 期
A CLINICAL TRIAL ON EFFECT OF SINGLE DOSE FENOFIBRATE AS AN ADJUNCT TO PHOTOTHERAPY IN NEONATAL JAUNDICECTRI/2023/03/050811Deepaa S94
已完成
3 期
Fenofibrate in PSCIRCT20200427047225N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
Prevention effect of fenofibrate/pioglitazone in obese diabetic patientsNutritional, Metabolic, EndocrineT2DM, obesityPACTR201407000856135faculty of pharmacy, ain shams university60
已完成
3 期
Evaluation of efficacy and safety of Fenofibrate in COVID-19 patientsIRCT20220612055149N1Artesh University of Medical Sciences70